Global Bi-Specific MAbS Market Growth (Status and Outlook) 2022-2028
- LP 4883081
- 113 Pages
- March 2022
- Pharmaceuticals
The United States Bi-Specific MAbS market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bi-Specific MAbS market, reaching US$ million by the year 2028. As for the Europe Bi-Specific MAbS landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bi-Specific MAbS players cover Johnson and Johnson, Novartis AG, Hoffmann-La Roche Ltd., and Chugai Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bi-Specific MAbS market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Catumaxomab
Blinatumomab
Duligotumab
SAR 156597
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Microbial Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Johnson and Johnson
Novartis AG
Hoffmann-La Roche Ltd.
Chugai Pharmaceutical
Bayer AG
Thermo Fisher Scientific
Bistro-Myers Squibb
Mylan N.V.
Daiichi Sankyo Company
Abbott
AstraZeneca
Eli Lilly
Merck and Co.
Amgen
Pfizer
GlaxoSmithKline plc
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bi-Specific MAbS Market Size 2017-2028
2.1.2 Bi-Specific MAbS Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bi-Specific MAbS Segment by Type
2.2.1 Catumaxomab
2.2.2 Blinatumomab
2.2.3 Duligotumab
2.2.4 SAR 156597
2.3 Bi-Specific MAbS Market Size by Type
2.3.1 Bi-Specific MAbS Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bi-Specific MAbS Market Size Market Share by Type (2017-2022)
2.4 Bi-Specific MAbS Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 Inflammatory Diseases
2.4.4 Infectious Diseases
2.4.5 Microbial Diseases
2.4.6 Others
2.5 Bi-Specific MAbS Market Size by Application
2.5.1 Bi-Specific MAbS Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bi-Specific MAbS Market Size Market Share by Application (2017-2022)
3 Bi-Specific MAbS Market Size by Player
3.1 Bi-Specific MAbS Market Size Market Share by Players
3.1.1 Global Bi-Specific MAbS Revenue by Players (2020-2022)
3.1.2 Global Bi-Specific MAbS Revenue Market Share by Players (2020-2022)
3.2 Global Bi-Specific MAbS Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bi-Specific MAbS by Regions
4.1 Bi-Specific MAbS Market Size by Regions (2017-2022)
4.2 Americas Bi-Specific MAbS Market Size Growth (2017-2022)
4.3 APAC Bi-Specific MAbS Market Size Growth (2017-2022)
4.4 Europe Bi-Specific MAbS Market Size Growth (2017-2022)
4.5 Middle East & Africa Bi-Specific MAbS Market Size Growth (2017-2022)
5 Americas
5.1 Americas Bi-Specific MAbS Market Size by Country (2017-2022)
5.2 Americas Bi-Specific MAbS Market Size by Type (2017-2022)
5.3 Americas Bi-Specific MAbS Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bi-Specific MAbS Market Size by Region (2017-2022)
6.2 APAC Bi-Specific MAbS Market Size by Type (2017-2022)
6.3 APAC Bi-Specific MAbS Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bi-Specific MAbS by Country (2017-2022)
7.2 Europe Bi-Specific MAbS Market Size by Type (2017-2022)
7.3 Europe Bi-Specific MAbS Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bi-Specific MAbS by Region (2017-2022)
8.2 Middle East & Africa Bi-Specific MAbS Market Size by Type (2017-2022)
8.3 Middle East & Africa Bi-Specific MAbS Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bi-Specific MAbS Market Forecast
10.1 Global Bi-Specific MAbS Forecast by Regions (2023-2028)
10.1.1 Global Bi-Specific MAbS Forecast by Regions (2023-2028)
10.1.2 Americas Bi-Specific MAbS Forecast
10.1.3 APAC Bi-Specific MAbS Forecast
10.1.4 Europe Bi-Specific MAbS Forecast
10.1.5 Middle East & Africa Bi-Specific MAbS Forecast
10.2 Americas Bi-Specific MAbS Forecast by Country (2023-2028)
10.2.1 United States Bi-Specific MAbS Market Forecast
10.2.2 Canada Bi-Specific MAbS Market Forecast
10.2.3 Mexico Bi-Specific MAbS Market Forecast
10.2.4 Brazil Bi-Specific MAbS Market Forecast
10.3 APAC Bi-Specific MAbS Forecast by Region (2023-2028)
10.3.1 China Bi-Specific MAbS Market Forecast
10.3.2 Japan Bi-Specific MAbS Market Forecast
10.3.3 Korea Bi-Specific MAbS Market Forecast
10.3.4 Southeast Asia Bi-Specific MAbS Market Forecast
10.3.5 India Bi-Specific MAbS Market Forecast
10.3.6 Australia Bi-Specific MAbS Market Forecast
10.4 Europe Bi-Specific MAbS Forecast by Country (2023-2028)
10.4.1 Germany Bi-Specific MAbS Market Forecast
10.4.2 France Bi-Specific MAbS Market Forecast
10.4.3 UK Bi-Specific MAbS Market Forecast
10.4.4 Italy Bi-Specific MAbS Market Forecast
10.4.5 Russia Bi-Specific MAbS Market Forecast
10.5 Middle East & Africa Bi-Specific MAbS Forecast by Region (2023-2028)
10.5.1 Egypt Bi-Specific MAbS Market Forecast
10.5.2 South Africa Bi-Specific MAbS Market Forecast
10.5.3 Israel Bi-Specific MAbS Market Forecast
10.5.4 Turkey Bi-Specific MAbS Market Forecast
10.5.5 GCC Countries Bi-Specific MAbS Market Forecast
10.6 Global Bi-Specific MAbS Forecast by Type (2023-2028)
10.7 Global Bi-Specific MAbS Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Information
11.1.2 Johnson and Johnson Bi-Specific MAbS Product Offered
11.1.3 Johnson and Johnson Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson and Johnson Main Business Overview
11.1.5 Johnson and Johnson Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Bi-Specific MAbS Product Offered
11.2.3 Novartis AG Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Information
11.3.2 Hoffmann-La Roche Ltd. Bi-Specific MAbS Product Offered
11.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hoffmann-La Roche Ltd. Main Business Overview
11.3.5 Hoffmann-La Roche Ltd. Latest Developments
11.4 Chugai Pharmaceutical
11.4.1 Chugai Pharmaceutical Company Information
11.4.2 Chugai Pharmaceutical Bi-Specific MAbS Product Offered
11.4.3 Chugai Pharmaceutical Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Chugai Pharmaceutical Main Business Overview
11.4.5 Chugai Pharmaceutical Latest Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Information
11.5.2 Bayer AG Bi-Specific MAbS Product Offered
11.5.3 Bayer AG Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer AG Main Business Overview
11.5.5 Bayer AG Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Bi-Specific MAbS Product Offered
11.6.3 Thermo Fisher Scientific Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Bistro-Myers Squibb
11.7.1 Bistro-Myers Squibb Company Information
11.7.2 Bistro-Myers Squibb Bi-Specific MAbS Product Offered
11.7.3 Bistro-Myers Squibb Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bistro-Myers Squibb Main Business Overview
11.7.5 Bistro-Myers Squibb Latest Developments
11.8 Mylan N.V.
11.8.1 Mylan N.V. Company Information
11.8.2 Mylan N.V. Bi-Specific MAbS Product Offered
11.8.3 Mylan N.V. Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Mylan N.V. Main Business Overview
11.8.5 Mylan N.V. Latest Developments
11.9 Daiichi Sankyo Company
11.9.1 Daiichi Sankyo Company Company Information
11.9.2 Daiichi Sankyo Company Bi-Specific MAbS Product Offered
11.9.3 Daiichi Sankyo Company Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Daiichi Sankyo Company Main Business Overview
11.9.5 Daiichi Sankyo Company Latest Developments
11.10 Abbott
11.10.1 Abbott Company Information
11.10.2 Abbott Bi-Specific MAbS Product Offered
11.10.3 Abbott Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Abbott Main Business Overview
11.10.5 Abbott Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Bi-Specific MAbS Product Offered
11.11.3 AstraZeneca Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly Bi-Specific MAbS Product Offered
11.12.3 Eli Lilly Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Eli Lilly Main Business Overview
11.12.5 Eli Lilly Latest Developments
11.13 Merck and Co.
11.13.1 Merck and Co. Company Information
11.13.2 Merck and Co. Bi-Specific MAbS Product Offered
11.13.3 Merck and Co. Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Merck and Co. Main Business Overview
11.13.5 Merck and Co. Latest Developments
11.14 Amgen
11.14.1 Amgen Company Information
11.14.2 Amgen Bi-Specific MAbS Product Offered
11.14.3 Amgen Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Amgen Main Business Overview
11.14.5 Amgen Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Bi-Specific MAbS Product Offered
11.15.3 Pfizer Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 GlaxoSmithKline plc
11.16.1 GlaxoSmithKline plc Company Information
11.16.2 GlaxoSmithKline plc Bi-Specific MAbS Product Offered
11.16.3 GlaxoSmithKline plc Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 GlaxoSmithKline plc Main Business Overview
11.16.5 GlaxoSmithKline plc Latest Developments
11.17 Roche
11.17.1 Roche Company Information
11.17.2 Roche Bi-Specific MAbS Product Offered
11.17.3 Roche Bi-Specific MAbS Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Roche Main Business Overview
11.17.5 Roche Latest Developments
12 Research Findings and Conclusion
Table 1. Bi-Specific MAbS Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Catumaxomab
Table 3. Major Players of Blinatumomab
Table 4. Major Players of Duligotumab
Table 5. Major Players of SAR 156597
Table 6. Bi-Specific MAbS Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Bi-Specific MAbS Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Bi-Specific MAbS Market Size Market Share by Type (2017-2022)
Table 9. Bi-Specific MAbS Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Bi-Specific MAbS Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Bi-Specific MAbS Market Size Market Share by Application (2017-2022)
Table 12. Global Bi-Specific MAbS Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Bi-Specific MAbS Revenue Market Share by Player (2020-2022)
Table 14. Bi-Specific MAbS Key Players Head office and Products Offered
Table 15. Bi-Specific MAbS Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Bi-Specific MAbS Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Bi-Specific MAbS Market Size Market Share by Regions (2017-2022)
Table 20. Americas Bi-Specific MAbS Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Bi-Specific MAbS Market Size Market Share by Country (2017-2022)
Table 22. Americas Bi-Specific MAbS Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Bi-Specific MAbS Market Size Market Share by Type (2017-2022)
Table 24. Americas Bi-Specific MAbS Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Bi-Specific MAbS Market Size Market Share by Application (2017-2022)
Table 26. APAC Bi-Specific MAbS Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Bi-Specific MAbS Market Size Market Share by Region (2017-2022)
Table 28. APAC Bi-Specific MAbS Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Bi-Specific MAbS Market Size Market Share by Type (2017-2022)
Table 30. APAC Bi-Specific MAbS Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Bi-Specific MAbS Market Size Market Share by Application (2017-2022)
Table 32. Europe Bi-Specific MAbS Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Bi-Specific MAbS Market Size Market Share by Country (2017-2022)
Table 34. Europe Bi-Specific MAbS Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Bi-Specific MAbS Market Size Market Share by Type (2017-2022)
Table 36. Europe Bi-Specific MAbS Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Bi-Specific MAbS Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Bi-Specific MAbS Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Bi-Specific MAbS Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Bi-Specific MAbS Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bi-Specific MAbS Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Bi-Specific MAbS Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Bi-Specific MAbS Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Bi-Specific MAbS
Table 45. Key Market Challenges & Risks of Bi-Specific MAbS
Table 46. Key Industry Trends of Bi-Specific MAbS
Table 47. Global Bi-Specific MAbS Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Bi-Specific MAbS Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Bi-Specific MAbS Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Bi-Specific MAbS Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Bi-Specific MAbS Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Bi-Specific MAbS Market Size Market Share Forecast by Application (2023-2028)
Table 53. Johnson and Johnson Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 54. Johnson and Johnson Bi-Specific MAbS Product Offered
Table 55. Johnson and Johnson Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Johnson and Johnson Main Business
Table 57. Johnson and Johnson Latest Developments
Table 58. Novartis AG Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 59. Novartis AG Bi-Specific MAbS Product Offered
Table 60. Novartis AG Main Business
Table 61. Novartis AG Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Novartis AG Latest Developments
Table 63. Hoffmann-La Roche Ltd. Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 64. Hoffmann-La Roche Ltd. Bi-Specific MAbS Product Offered
Table 65. Hoffmann-La Roche Ltd. Main Business
Table 66. Hoffmann-La Roche Ltd. Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Hoffmann-La Roche Ltd. Latest Developments
Table 68. Chugai Pharmaceutical Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 69. Chugai Pharmaceutical Bi-Specific MAbS Product Offered
Table 70. Chugai Pharmaceutical Main Business
Table 71. Chugai Pharmaceutical Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Chugai Pharmaceutical Latest Developments
Table 73. Bayer AG Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 74. Bayer AG Bi-Specific MAbS Product Offered
Table 75. Bayer AG Main Business
Table 76. Bayer AG Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Bayer AG Latest Developments
Table 78. Thermo Fisher Scientific Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 79. Thermo Fisher Scientific Bi-Specific MAbS Product Offered
Table 80. Thermo Fisher Scientific Main Business
Table 81. Thermo Fisher Scientific Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Thermo Fisher Scientific Latest Developments
Table 83. Bistro-Myers Squibb Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 84. Bistro-Myers Squibb Bi-Specific MAbS Product Offered
Table 85. Bistro-Myers Squibb Main Business
Table 86. Bistro-Myers Squibb Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Bistro-Myers Squibb Latest Developments
Table 88. Mylan N.V. Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 89. Mylan N.V. Bi-Specific MAbS Product Offered
Table 90. Mylan N.V. Main Business
Table 91. Mylan N.V. Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Mylan N.V. Latest Developments
Table 93. Daiichi Sankyo Company Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 94. Daiichi Sankyo Company Bi-Specific MAbS Product Offered
Table 95. Daiichi Sankyo Company Main Business
Table 96. Daiichi Sankyo Company Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Daiichi Sankyo Company Latest Developments
Table 98. Abbott Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 99. Abbott Bi-Specific MAbS Product Offered
Table 100. Abbott Main Business
Table 101. Abbott Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Abbott Latest Developments
Table 103. AstraZeneca Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 104. AstraZeneca Bi-Specific MAbS Product Offered
Table 105. AstraZeneca Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. Eli Lilly Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 109. Eli Lilly Bi-Specific MAbS Product Offered
Table 110. Eli Lilly Main Business
Table 111. Eli Lilly Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Eli Lilly Latest Developments
Table 113. Merck and Co. Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 114. Merck and Co. Bi-Specific MAbS Product Offered
Table 115. Merck and Co. Main Business
Table 116. Merck and Co. Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Merck and Co. Latest Developments
Table 118. Amgen Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 119. Amgen Bi-Specific MAbS Product Offered
Table 120. Amgen Main Business
Table 121. Amgen Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Amgen Latest Developments
Table 123. Pfizer Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 124. Pfizer Bi-Specific MAbS Product Offered
Table 125. Pfizer Main Business
Table 126. Pfizer Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Pfizer Latest Developments
Table 128. GlaxoSmithKline plc Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 129. GlaxoSmithKline plc Bi-Specific MAbS Product Offered
Table 130. GlaxoSmithKline plc Main Business
Table 131. GlaxoSmithKline plc Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. GlaxoSmithKline plc Latest Developments
Table 133. Roche Details, Company Type, Bi-Specific MAbS Area Served and Its Competitors
Table 134. Roche Bi-Specific MAbS Product Offered
Table 135. Roche Main Business
Table 136. Roche Bi-Specific MAbS Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. Roche Latest Developments
List of Figures
Figure 1. Bi-Specific MAbS Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bi-Specific MAbS Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Bi-Specific MAbS Market Size Market Share by Type in 2021
Figure 7. Bi-Specific MAbS in Cancer
Figure 8. Global Bi-Specific MAbS Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Bi-Specific MAbS in Autoimmune Diseases
Figure 10. Global Bi-Specific MAbS Market: Autoimmune Diseases (2017-2022) & ($ Millions)
Figure 11. Bi-Specific MAbS in Inflammatory Diseases
Figure 12. Global Bi-Specific MAbS Market: Inflammatory Diseases (2017-2022) & ($ Millions)
Figure 13. Bi-Specific MAbS in Infectious Diseases
Figure 14. Global Bi-Specific MAbS Market: Infectious Diseases (2017-2022) & ($ Millions)
Figure 15. Bi-Specific MAbS in Microbial Diseases
Figure 16. Global Bi-Specific MAbS Market: Microbial Diseases (2017-2022) & ($ Millions)
Figure 17. Bi-Specific MAbS in Others
Figure 18. Global Bi-Specific MAbS Market: Others (2017-2022) & ($ Millions)
Figure 19. Global Bi-Specific MAbS Market Size Market Share by Application in 2021
Figure 20. Global Bi-Specific MAbS Revenue Market Share by Player in 2021
Figure 21. Global Bi-Specific MAbS Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Bi-Specific MAbS Market Size 2017-2022 ($ Millions)
Figure 23. APAC Bi-Specific MAbS Market Size 2017-2022 ($ Millions)
Figure 24. Europe Bi-Specific MAbS Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Bi-Specific MAbS Market Size 2017-2022 ($ Millions)
Figure 26. Americas Bi-Specific MAbS Value Market Share by Country in 2021
Figure 27. Americas Bi-Specific MAbS Consumption Market Share by Type in 2021
Figure 28. Americas Bi-Specific MAbS Market Size Market Share by Application in 2021
Figure 29. United States Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Bi-Specific MAbS Market Size Market Share by Region in 2021
Figure 34. APAC Bi-Specific MAbS Market Size Market Share by Application in 2021
Figure 35. China Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Bi-Specific MAbS Market Size Market Share by Country in 2021
Figure 42. Europe Bi-Specific MAbS Market Size Market Share by Type in 2021
Figure 43. Europe Bi-Specific MAbS Market Size Market Share by Application in 2021
Figure 44. Germany Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Bi-Specific MAbS Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Bi-Specific MAbS Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Bi-Specific MAbS Market Size Market Share by Application in 2021
Figure 52. Egypt Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Bi-Specific MAbS Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 58. APAC Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 59. Europe Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 61. United States Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 62. Canada Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 65. China Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 66. Japan Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 67. Korea Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 69. India Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 70. Australia Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 71. Germany Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 72. France Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 73. UK Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 74. Italy Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 75. Russia Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 76. Spain Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 79. Israel Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Bi-Specific MAbS Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
